Biomimetic synthesis of L-DOPA inspired by tyrosine hydroxylase

被引:6
|
作者
Du, Dong [1 ]
Su, Yingli [1 ]
Shang, Qi [1 ]
Chen, Chan [1 ]
Tang, Weikang [1 ]
Zhang, Ling [1 ]
Ren, Haisheng [1 ]
Liu, Wenbin [1 ]
机构
[1] Sichuan Univ, Sch Chem Engn, Dept Pharmaceut & Biol Engn, Chengdu 610065, Peoples R China
基金
中国国家自然科学基金;
关键词
Biomimetic synthesis; L-DOPA; Tyrosine; Hydroxylase; Fe2+; EDTA; FERROUS IRON; MECHANISM; TRYPTOPHAN; OXIDATION; RADICALS; OXYGEN; EDTA;
D O I
10.1016/j.jinorgbio.2022.111878
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
L-3,4-dihydroxyphenylalanine (L-DOPA) is in high demand as the cornerstone for treatment of Parkinson's disease. The current production of L-DOPA is associated with poor productivity and long production period. Biomimetic system inspired from tyrosine hydroxylase was developed to achieve the production of L-DOPA from tyrosine with high reactivity, efficiency, and specificity. The biomimetic system owned close resemblance of component and structure in comparison with tyrosine hydroxylase, consisting of tyrosine as substrate, a redox complex of Fe2+ and EDTA as the catalyst to simulate the active center of the natural tyrosine hydroxylase, hydrogen peroxide as the oxidant, and ascorbic acid as the reductant. HPLC, HPLC-MS/MS, 1H NMR, and specific rotation identified L-DOPA was generated. The system showed high catalytic activity and regioselectivity for hydroxylation of tyrosine as equal to tyrosine hydroxylase. FeIVO2+ was formed as the major active species, and NIH shift was observed. EDTA accelerated the reaction by reducing the redox potential of Fe3+/Fe2+ couple. Density functional theory calculation suggested formation of FeIVO2+ was more thermodynamically favorable. The biomimetic system shared analogous catalytic mechanism with TyrH. Process parameters was optimized for maximum production of L-DOPA, namely 6.4 mM tyrosine, 1.6 mM Fe2+, 1.92 mM EDTA, 150 mM H2O2, and 35 mM ascorbic acid in 0.2 M glycine-HCl buffer at pH 4.5 and 60. C. The yield, titer, and productivity were obtained as 52.01%, 3.22 mM, and 48,210.68 mg L-1 h(-1), respectively. The proposed method exhibited an amazing productivity, might provide a promising strategy to industrialize L-DOPA production.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [41] Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker
    Stoitchkov, K
    Letellier, S
    Garnier, JP
    Bousquet, B
    Tsankov, N
    Morel, P
    Ghanem, G
    Le Bricon, T
    MELANOMA RESEARCH, 2003, 13 (06) : 587 - 593
  • [42] RISKS OF PARKINSONISM TREATMENT WITH L-DOPA AND L-DOPA DECARBOXYLASE INHIBITOR
    JORG, J
    MEDIZINISCHE WELT, 1979, 30 (46): : 1740 - 1742
  • [43] Synthesis of L-Dopa Modifier L-Dopa-L-His and its Interaction with DNA
    Zhao, Dongxin
    Ma, Li
    Lu, Kui
    LETTERS IN ORGANIC CHEMISTRY, 2015, 12 (07) : 459 - 464
  • [44] METHYLDOPA AND L-DOPA
    不详
    POSTGRADUATE MEDICINE, 1970, 47 (06) : 22 - &
  • [45] L-DOPA AND FAVISM
    BEUTLER, E
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 36 (04): : 523 - &
  • [46] PRESCRIBING OF L-DOPA
    DINGLE, CJ
    MEDICAL JOURNAL OF AUSTRALIA, 1971, 1 (19) : 1034 - &
  • [47] CARDIOLOGIST AND L-DOPA
    DUCLOUX, G
    MOUTON, Y
    WAREMBOURG, H
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1972, 21 (06): : 545 - 553
  • [48] L-DOPA FOR PARKINSONISM
    REVENO, WS
    BAUER, RB
    ROSENBAUM, H
    GERIATRICS, 1973, 28 (01) : 86 - 88
  • [49] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND AN ASSOCIATION L-DOPA PLUS A DOPA DECARBOXYLASE INHIBITOR
    FAZIO, C
    BARBA, C
    CASACCHIA, M
    AGNOLI, A
    RUGGIERI, S
    VOLANTE, F
    REITANO, M
    ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 347 - +
  • [50] Protein L-Dopa as an index of hydroxyl radical attack on protein tyrosine
    Cohen, G
    Yakushin, S
    Dembiec-Cohen, D
    ANALYTICAL BIOCHEMISTRY, 1998, 263 (02) : 232 - 239